Robert I. Glazer
Impact in
- Oncology top 1%
- Cancer Cells and Metastasis
- Drug Transport and Resistance Mechanisms
- Molecular Biology top 1%
- Biochemical and Molecular Research
- Protein Kinase Regulation and GTPase Signaling
- RNA modifications and cancer
- Cancer therapeutics and mechanisms
Papers in
-
- Biochemical and Molecular Research 25
- RNA modifications and cancer 21
- Cancer therapeutics and mechanisms 16
- Protein Kinase Regulation and GTPase Signaling 14
- Peroxisome Proliferator-Activated Receptors 14
- Oncology 52
- Cancer-related Molecular Pathways 12
- Cancer Cells and Metastasis 11
- Co-authors
- Shakeel AhmadFlavia BorelliniKathleen D. HartmanXiaoyun ZengHongyan YuanGang YuChristian RohlffYuzhi Yin
- Journals
- Molecular Pharmacology (23 papers)Biochemical Pharmacology (23 papers)Journal of Biological Chemistry (11 papers)Biochemical and Biophysical Research Communications (11 papers)Cancer Research (6 papers)
- Partner nations
- United StatesMalaysiaChina
In The Last Decade
Robert I. Glazer
204 papers receiving 6.8k citations
Peers
Comparison fields: 5 of 133
- Oncology 1.9k
- Molecular Biology 4.6k
- Cancer Research 886
- Physiology 260
- Toxicology 119
Countries citing papers authored by Robert I. Glazer
This map shows the geographic impact of Robert I. Glazer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert I. Glazer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert I. Glazer more than expected).
Fields of papers citing papers by Robert I. Glazer
This network shows the impact of papers produced by Robert I. Glazer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert I. Glazer. The network helps show where Robert I. Glazer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert I. Glazer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 74 | |
| 2 | 2018 | 13 | |
| 3 | 2013 | 46 | |
| 4 | 2012 | 2 | |
| 5 | 2011 | 12 | |
| 6 | 2011 | 41 | |
| 7 | 2009 | 38 | |
| 8 | 2008 | 36 | |
| 9 | 2006 | 32 | |
| 10 | 2006 | 49 | |
| 11 | Inhibition of Eg5 (kinesin-like 1) with Antisense Oligonucleotides leads to cell-cycle arrest in G2/M and antitumor activity against xenograft tumors | 2005 | 1 |
| 12 | 1997 | 191 | |
| 13 | 1995 | 22 | |
| 14 | 1993 | 12 | |
| 15 | 1991 | 3 | |
| 16 | Potentiation of the cytocidal effect of human immune interferon by different synthetic double-stranded RNAs in the refractory human colon carcinoma cell line BE. | 1986 | 6 |
| 17 | Synergistic effect of human immune interferon and double-stranded RNA against human colon carcinoma cells in vitro. | 1985 | 10 |
| 18 | 1985 | 5 | |
| 19 | 1978 | 2 | |
| 20 | 2-Acetylaminofluorene and N-hydroxy-2-acetylaminofluorene inhibition of incorporation of orotic acid-5-3H into nuclear ribosomal and heterogeneous RNA in normal and regenerating liver. | 1974 | 20 |
About Robert I. Glazer
Robert I. Glazer is a scholar working on Molecular Biology, Oncology, Cancer Research, Toxicology and Physiology, having authored 206 papers that have together received 7.0k indexed citations. Recurring topics across this work include Biochemical and Molecular Research (25 papers), RNA modifications and cancer (21 papers), Cancer therapeutics and mechanisms (16 papers), Protein Kinase Regulation and GTPase Signaling (14 papers), Peroxisome Proliferator-Activated Receptors (14 papers), Cancer-related Molecular Pathways (12 papers), Cancer Cells and Metastasis (11 papers) and HIV/AIDS drug development and treatment (11 papers). The work is most often cited by research in Oncology (1.9k citations), Molecular Biology (4.6k citations), Cancer Research (886 citations), Physiology (260 citations) and Toxicology (119 citations). Robert I. Glazer has collaborated with scholars based in United States, Malaysia and China. Frequent co-authors include Shakeel Ahmad, Flavia Borellini, Kathleen D. Hartman, Xiaoyun Zeng, Hongyan Yuan, Gang Yu, Christian Rohlff, Yuzhi Yin, Lijie Grace Zhang and Wei Zhu. Their work appears in journals such as Molecular Pharmacology, Biochemical Pharmacology, Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.